Cdk2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
CDK2 encodes cyclin-dependent kinase 2, a serine/threonine kinase that plays central roles in cell cycle regulation, particularly at the G1/S and S phase transitions. CDK2 forms complexes with cyclin E (G1/S) and cyclin A (S phase) to drive cells through S phase and into G2. While CDK2 is essential for cell proliferation, it also has important functions in post-mitotic [neurons](/entities/neurons) related to synaptic plasticity, DNA repair, and neuronal survival [@cyclindependent2001][@cdk2005].
Gene Information
Gene Structure
CDK2 spans ~3.5 kb:
Exons: 9 coding exons
Transcript: ~1.8 kb mRNA
Protein: 297 amino acids, ~34 kDa
Normal Function
Cell Cycle
CDK2 regulates:
G1/S transition — With cyclin E
S phase — With cyclin A
Centrosome cycle — Duplication
Histone synthesis — S-phase genes
DNA Replication
CDK2 in:
Origin firing — Replication start
Replication forks — Fork progression
Repair — Coordinates with repair
Neuronal Functions
In neurons:
Synaptic plasticity — AMPA receptor trafficking
DNA repair — Neuronal genome maintenance
Survival signaling — Can be pro- or anti-death
Role in Neurodegeneration
Alzheimer's Disease
CDK2 in AD:
Cell cycle re-entry — Inappropriate activation
[Tau](/proteins/tau) phosphorylation — CDK2 can phosphorylate [tau](/proteins/tau)
Neuronal death — Contributes to degeneration
Parkinson's Disease
Cell cycle activation — Seen in PD
Dopaminergic loss — CDK2 in neuron death
Stroke
Ischemic injury — CDK2 after stroke
Key Publications
PMID: 8340146(https://pubmed.ncbi.nlm.nih.gov/8340146/) — Discovery of CDK2
PMID: 10625657(https://pubmed.ncbi.nlm.nih.gov/10625657/) — CDK2 structure and function
PMID: 11025718(https://pubmed.ncbi.nlm.nih.gov/11025718/) — CDK2 in cell cycle
PMID: 21479819(https://pubmed.ncbi.nlm.nih.gov/21479819/) — CDK2 in neurodegeneration
The study of Cdk2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Cell Cycle Regulation
CDK2 in Cell Cycle
CDK2 plays essential roles:
[G1/S transition: Partners with cyclin E](/genes/ran)
[S phase: Cyclin A/CDK2 drives DNA replication](/genes/cat)
Tau pathology: Phosphorylates tau at AD-relevant sites
Parkinson's Disease
Cell death pathways: Contributes to dopaminergic neuron loss
[α-Synuclein](/proteins/alpha-synuclein): May phosphorylate synuclein
Mitochondrial dysfunction: Links to PD pathology
Animal Models
Knockout Studies
Cdk2 knockout mice:
Viable but sterile: Adult mice survive
Cell proliferation: Reduced in some tissues
DNA replication: Impaired S phase
Compensation: CDK1 can compensate
Transgenic Models
Neuronal expression: Cell cycle models in brain
Alzheimer's models: Crossed with [APP](/entities/app-protein)/PS1
Conditional knockouts: Tissue-specific studies
Therapeutic Targeting
CDK Inhibitors
Challenges
Toxicity: CDK2 inhibition affects proliferation
CNS penetration: Brain delivery challenges
Therapeutic window: Balancing efficacy and safety
Specificity: Achieving selectivity
Summary
CDK2 is a central cell cycle kinase with dual roles in normal cell division and pathological neuronal cell cycle re-entry in neurodegeneration. Understanding its regulation in neurons provides therapeutic opportunities for AD and PD.